Association of the β3-adrenergic receptor Trp64Arg polymorphism with common metabolic traits: Studies of 7605 middle-aged white people

Molecular Genetics and Metabolism

Volumn 94, Issue 1, 2008, Pages 90-97

  Gjesing, A P ^a   Andersen, G ^a   Borch Johnsen, K ^a,b,c   Jorgensen T ^b   Hansen, T ^a   Pedersen, O ^a,c  

^a STENO DIABETES CENTER   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

Adrenergic receptor; Association; Diabetes; Epidemiology; Genetics; Insulin resistance; Obesity

Indexed keywords

ARGININE; BETA 3 ADRENERGIC RECEPTOR; GLUCOSE; INSULIN; TRYPTOPHAN;

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DENMARK; DIABETOGENESIS; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POPULATION RESEARCH; PRIORITY JOURNAL; QUANTITATIVE GENETICS; SEX RATIO; STATISTICAL SIGNIFICANCE; CAUCASIAN; ETHNOLOGY; GENETIC VARIABILITY; GENETICS; GENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM;

ARGININE; DENMARK; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, BETA-3; TRYPTOPHAN; VARIATION (GENETICS);

EID: 41949103987     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2007.12.003     Document Type: Article

References (52)

1. 3-adrenergic receptor mRNA in man. J. Clin. Invest. 91 (1993) 344-349
2. Lafontan M., and Berlan M. Fat cell adrenergic receptors and the control of white and brown fat cell function. J. Lipid. Res. 34 (1993) 1057-1091
3. 3-adrenergic receptor gene. N. Engl. J. Med. 333 (1995) 343-347
4. 3-adrenergic agonists in transfected 3T3-Li preadipocytes. Horm. Metab. Res. 32 (2000) 91-96
5. Piétri-Rouxel F., Manning B.S., Gros J., and Strosberg D. The biochemical effect of the naturally occurring Trp64→Arg mutation on human β3-adrenoceptor activity. Eur. J. Biochem. 247 (1997) 1174-1179
6. 1-adrenergic receptor in adipose tissue of congenitally obese (C57BL/6J ob/ob) mice. Mol. Endocrinol. 8 (1994) 518-527
7. 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N. Engl. J. Med. 333 (1995) 352-354
8. 3-adrenergic receptor gene is not associated with obesity or type 2 diabetes mellitus in a large population-based Caucasian cohort. J. Clin. Endocrinol. Metab. 83 (1998) 2892-2897
9. 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N. Engl. J. Med. 333 (1995) 348-351
10. 3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem. Biophys. Res. Commun. 215 (1995) 555-560
11. 3-adrenergic receptor gene with body mass index. J. Clin. Endocrinol. Metab. 83 (1998) 2441-2444
12. 3-adrengic receptor gene polymorphism in Japanese: meta-analysis. Obes. Res. 9 (2001) 741-745
13. 3-adrenergic receptor with body mass index. Int. J. Obes. 22 (1998) 559-566
14. Mitchell B.D., Cole S.A., Comuzzie A.G., Almasy L., Blangero J., MacCluer J.W., and Hixson J.E. A quantitative trait locus influencing BMI maps to the region of the β-3 Adrenergic Receptor. Diabetes 48 (1999) 1863-1867
15. Mitchell T.H., Ellis R.D.M., Smith S.A., Robb S.G., and Cawthorne M.A. Effects of BRL 35135, a β-adrenoceptor agonist with novel selectivity, on glucose tolerance and insulin sensitivity in obese subjects. Int. J. Obes. 13 (1989) 757-766
16. Umekawa T., Yoshida T., Sakane N., Saito M., Kumamoto K., and Kondo M. Anti-obesity and anti-diabetic effects of CL316,243, a highly specific beta 3-adrenoceptor agonist, in Otsuka Long-Evans Tokushima fatty rats: induction of uncoupling protein and activation of glucose transporter 4 in white fat. Eur. J. Endocrinol. 136 (1997) 429-437
17. 3-adrenergic receptor is associated with type 2 diabetes and obesity in a large Japanese sample. Diabetes Care 24 (2001) 1579-1583
18. Walston J., Silver K., Hilfiker H., Andersen R.E., Seibert M., Beamer B., Roth J., Poehlman E., and Shuldiner A.R. Insulin response to glucose is lower in individuals homozygous for the Arg64 variant of the β-3-adrenergic receptor. J. Clin. Endocrinol. Metab. 85 (2000) 4019-4022
19. 3-adrenergic receptor gene. Diabetes 45 (1996) 1115-1120
20. 3-adrenergic receptor gene polymorphism with insulin resistance in Japanese-American men. Metabolism 48 (1999) 1367-1370
21. 3-adrenergic-receptor with NIDDM and body weight gain. Diabetologia 39 (1996) 349-352
22. 3 adrenergic receptor with insulin resistance. Obes. Res. 13 (2005) 1709-1719
23. Parikh H., and Groop L. Candidate genes for type 2 diabetes. Rev. Endocr. Metab. Disord. 5 (2004) 151-176
24. Jørgensen T., Borch-Johnsen K., Thomsen T.F., Ibsen H., Glümer C., and Pisinger C. A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99 (1). Eur. J. Cardiovasc. Prev. Rehabil. 10 (2003) 377-386
25. World Health Organization Diagnosis and Classification of Diabetes Mellitus: Report of a WHO Consultation. Part 1. Geneva, World Health Org. (1999).
26. Buetow K.H., Edmonson M., MacDonald R., Clifford R., Yip P., Kelley J., Little D.P., Strausberg R., Koester H., Cantor C.R., and Braun A. High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc. Natl. Acad. Sci. USA 98 (2001) 581-584
27. 3-adrenergic receptor gene. J. Biol. Chem. 270 (1995) 29483-29492
28. 3-adrenergic-receptor polymorphism: a genetic marker for visceral fat obesity and the insulin resistance syndrome. Diabetologia 40 (1997) 200-204
29. 3-adrenoceptor gene polymorphism (Trp64Arg) in obese diabetic and non-diabetic subjects. Clin. Exp. Pharmacol. Physiol. 24 (1997) 733-735
30. 3-adrenergic receptor gene. Diabetes Care 20 (1997) 1319-1323
31. 3-adrenergic receptor gene polymorphism and type 2 diabetes in a Caucasian population. Diabetes Obes. Metab. 3 (2001) 47-51
32. Carlsson M., Orho-Melander M., Hedenbro J., and Groop L.C. Common variants in the β2-(Gln27Glu) and β3-(Trp64Arg)-adrenoceptor genes are associated with elevated serum NEFA concentrations and Type II diabetes. Diabetologia 44 (2001) 629-636
33. 3-adrenergic receptor gene is not associated with coronary heart disease or insulin resistance in nondiabetic subjects and non-insulin-dependent diabetic patients. Metabolism 48 (1999) 853-856
34. Kasznicki J., Blasiak J., Majsterek I., Przybylowska K., and Drzewoski J. The Trp64Arg β3-adrenergic receptor amino-acid variant in not associated with overweight and type 2 diabetes mellitus in Polish population. Exp. Clin. Endocrinol. Diabetes. 113 (2005) 593-597
35. Evans D., Minouchehr S., Hagemann G., Mann W.A., Wendt D., Wolf A., and Beisiegel U. Frequency of and interaction between polymorphisms in the β3-adrenergic receptor and in uncoupling protein 1 and 2 and obesity in Germans. Int. J. Obes. 24 (2000) 1239-1245
36. 3-adrenergic receptor and glucose tolerance in the Dutch population. Clin. Endocrinol. 49 (1998) 229-234
37. Vendrell J., Gutierrez C., Broch M., Fernandez J.M., Aguilar C., and Richart C. β3-adrenoreceptor gene polymorphism and leptin. Lack of relationship in type 2 diabetic patients. Clin. Endocrinol. 49 (1998) 679-683
38. 3-adrenergic receptor expression in 3T3-F442A adipocytes: A mechanism for repression the cAMP signalling pathway. Proc. Natl. Acad. Sci. USA 91 (1994) 5677-5681
39. Anthony A., Sim R., Guiollaume J.L., Strosberg A.D., Dhillon A.P., Pounder R.E., and Wakefield A.F. Beta(β)3-adrenergic receptor in human pancreatic islet and duodenal somatostatin neuroendocrine cells. Aliment. Pharmacol. Ther. 14 (2000) 579-585
40. 3-adrenergic receptor exhibit abnormal insulin secretory activity. J. Mol. Endocrinol. 27 (2001) 133-144
41. Wahrenberg H., Lönnqvist F., and Arner P. Mechanisms underlying regional differences in lipolysis in human adipose tissue. J. Clin. Invest. 84 (1989) 458-467
42. Hegele R.A., Harris S.B., Hanley A.J.G., Azouz H., Connely P.W., and Zinman B. Absence of association between genetic variation of the beta 3-adrenergic receptor and metabolic phenotypes in Oji-Cree. Diabetes Care 21 (1998) 851-854
43. 3-adrenergic receptor and obesity in Mexican Americans. Hum. Genet. 101 (1997) 306-311
44. 3-adrenergic receptor and insulin sensitivity in subjects with glucose intolerance. Intern. Med. 36 (1997) 603-606
45. 3-adrenergic receptor gene in impaired glucose tolerance, non-insulin-dependent diabetes mellitus, and insulin resistance in Japanese subjects. Metabolism 47 (1998) 456-460
46. 3-adrenergic receptor gene and obesity in Japanese men: a longitudinal analysis. J. Clin. Endocrinol. Metab. 82 (1997) 1284-1287
47. 3-adrenergic receptor in Japanese NIDDM patients. Diabetes Care 19 (1996) 271-272
48. 3-adrenergic receptor in Japanese NIDDM patients. Diabetes Care 19 (1996) 1034-1035
49. 3-adrenergic receptor gene polymorphism is not a major genetic determinant of obesity and diabetes in Japanese general population. Diabetes. Res. Clin. Pract. 37 (1997) 1-7
50. 3-adrenergic receptor gene in Nauruans with obesity and noninsulin-dependent diabetes mellitus. J. Clin. Endocrin. Metab. 81 (1996) 4155-4158
51. 3-adrenergic receptor gene and obesity in Chinese subjects with components of the metabolic syndrome. Int. J. Obes. 24 (2000) 545-551
52. 3-adrenergic receptor gene in Japanese subjects. Metabolism 46 (1997) 199-202